All Stories

  1. All but Small: miRNAs from Wharton’s Jelly-Mesenchymal Stromal Cell Small Extracellular Vesicles Rescue Premature White Matter Injury after Intranasal Administration
  2. MicroRNA Cargo in Wharton’s Jelly MSC Small Extracellular Vesicles: Key Functionality to In Vitro Prevention and Treatment of Premature White Matter Injury
  3. Hyperuricemia during Pregnancy Leads to a Preeclampsia-Like Phenotype in Mice
  4. Intranasally Administered Exosomes from Umbilical Cord Stem Cells Have Preventive Neuroprotective Effects and Contribute to Functional Recovery after Perinatal Brain Injury
  5. Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury
  6. In vitro-microenvironment directs preconditioning of human chorion derived MSC promoting differentiation of OPC-like cells
  7. Extracellular Vesicles Derived from Wharton’s Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells
  8. 797: Wharton's jelly stem cell-derived extracellular vesicles drive neural progenitor cells towards oligodendroglial identity
  9. 798: Intranasal administration of extracellular vesicles derived from human umbilical cord mesenchymal stem cells as a potential treatment for perinatal brain damage
  10. Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact
  11. Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate
  12. 394: Neuro-protective and -regenerative effects of exosomes derived from Wharton's jelly mesenchymal stem cells
  13. Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage
  14. Mesenchymal stem/stromal cells—a key mediator for regeneration after perinatal morbidity?
  15. Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid
  16. 364: Neuroregenerative functions of transnasal delivered umbilical cord stem cells in a model of preterm hypoxic-ischemic brain injury
  17. PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling
  18. 294: Umbilical cord stem cells prime neural progenitor cells towards an oligodendrocyte fate
  19. 53: Successful transnasal delivery of stem cells in a rat model of perinatal hypoxic-ischemic brain injury
  20. 106: Synthetic preimplantation factor (sPIF*) promotes neuroprotection by modulating PKA/PKC kinases
  21. PreImplantation factor promotes neuroprotection by targeting microRNA let-7
  22. Umbilical Cord Stem Cells Induce Glial Fate in Neural Progenitor Cells
  23. Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells
  24. 786: Neurotrophic factors from human Wharton’s jelly mesenchymal stem cells induce gliogenesis
  25. 785: Neuroprotective role of Wharton’s jelly-derived mesenchymal stem cells in encephalopathy of prematurity (rat model)
  26. Stem Cells From Umbilical Cord Wharton’s Jelly From Preterm Birth Have Neuroglial Differentiation Potential
  27. 183: Human Wharton's jelly-derived mesenchymal stem cells express neurotrophic factors in vitro
  28. 432: Mesenchymal stem cell therapy of hypoxi/ischaemic brain damage
  29. O480 INTRACRANIAL MESENCHYMAL STEM CELL THERAPY IN A PERINATAL BRAIN DAMAGE MODEL
  30. Intrakraniale Stammzelltransplantation mit und ohne Erythropoietin erleichert die motorische Wiederherstellung bei perinataler Hirnschädigung im Rattenmodell
  31. 436: Preconditioning of chorion derived mesenchymal stem cells by different culture conditions for subsequent neural differentiation
  32. 54: Early intracranial mesenchymal stem cell therapy after a perinatal rat brain damage
  33. 428: Intracranial stem cell transplantation with and without erythropoietin facilitates motor recovery in a perinatal rat brain injury model
  34. 60: Umbilical cord Whartons jelly-derived mesenchymal stem cells have neural differentiation potential
  35. Placenta-derived Mesenchymal Stem Cells for the Neuroregeneration in a Rat Perinatal Brain Injury Model
  36. Homing of placenta-derived mesenchymal stem cells after perinatal intracerebral transplantation in a rat model
  37. Stammzelltransplantation bei Perinataler Hirnschädigung im Rattenmodell: Migration, Homing und Integration
  38. 399: Neural differentiation potential of human umbilical cord Whartons jelly-derived cells
  39. 400: Human embryonic stem cell-derived neuronal and oligodendrocyte progenitors are donor cell graft candidates for perinatal neuroregeneration
  40. 60: Engraftment of human placental-derived mesenchymal stem cells after intracerebral transplantation for neuroregeneration in a rodent model of perinatal brain injury
  41. Generation of an Osteogenic Graft From Human Placenta and Placenta-Derived Mesenchymal Stem Cells
  42. Perinatal Stem Cell Therapy
  43. Turning placenta into brain: placental mesenchymal stem cells differentiate into neurons and oligodendrocytes
  44. Fetal gene therapy: Opportunities and risks
  45. Placenta mesenchymal stem cells on a chorion scaffold as a potential osteogenic graft for peripartal bone regeneration
  46. Perinatal stem-cell and gene therapy for hemoglobinopathies
  47. Placental mesenchymal stem cells as potential grafts for peripartum osteogenic and neural regeneration
  48. 67: Placenta stem cells as autologous grafts for peripartum neuroregeneration - the neural differentiation potential of human placental mesenchymal stem cells
  49. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration
  50. Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses
  51. Simvastatin and vitamins C and E reduce a marker for atherosclerosis and endothelial activation
  52. Tissue-specific engraftment of mesenchymal stem cells after in-utero transplantation in ovine fetuses
  53. Engraftment Kinetics of Human Cord Blood and Murine Fetal Liver Stem Cells Following In Utero Transplantation into Immunodeficient Mice
  54. In utero transplantation of autologous and allogeneic fetal liver stem cells in ovine fetuses
  55. In utero transplantation of autologous and allogeneic fetal liver stem cells in fetal sheep
  56. Homing und Engraftment von autologen versus allogenen Stammzellen nach intrauteriner Transplantation im fetalen Schaf
  57. Engraftment of human cord blood-derived stem cells in preimmune ovine fetuses after ultrasound-guided in utero transplantation
  58. Ultrasound-guided stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy
  59. 512 Stem cell sampling from the first trimester fetus for prenatal ex-vivo gene therapy: Feasibility study
  60. Heat Shock Protein Upregulation Lowers Cytokine Levels after Ischemia and Reperfusion
  61. Scaffold Precoating with Human Autologous Extracellular Matrix for Improved Cell Attachment in Cardiovascular Tissue Engineering
  62. Expression of adhesion molecules and cytokines after coronary artery bypass grafting during normothermic and hypothermic cardiac arrest
  63. Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue
  64. Modified ultrafiltration lowers adhesion molecule and cytokine levels after cardiopulmonary bypass without clinical relevance in adults
  65. Tissue Engineering of a Bioprosthetic Heart Valve
  66. Tissue engineering in cardiovascular surgery: MTT, a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes1
  67. SCAFFOLD PRECOATING WITH HUMAN AUTOLO­GOUS EXTRACELLULAR MATRIX FOR IMPROVED CELL ATTACHMENT IN CARDIOVASCULAR TISSUE ENGINEERING
  68. Fluorescence activated cell sorting: A reliable method in tissue engineering of a bioprosthetic heart valve
  69. Lazaroid donor pretreatment does not improve lung allograft reperfusion injury in swine
  70. Tissue engineering: A new approach in cardiovascular surgery; Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh1
  71. A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
  72. Construction and Characterization of a 10-Genome Equivalent Yeast Artificial Chromosome Library for the Laboratory Rat,Rattus norvegicus
  73. Characterization of a set of variable number of tandem repeat markers conserved in Bovidae